788 related articles for article (PubMed ID: 15650235)
1. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
2. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
3. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
[TBL] [Abstract][Full Text] [Related]
4. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
Pastorino F; Mumbengegwi DR; Ribatti D; Ponzoni M; Allen TM
J Control Release; 2008 Feb; 126(1):85-94. PubMed ID: 18166243
[TBL] [Abstract][Full Text] [Related]
5. Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.
Brignole C; Marimpietri D; Pagnan G; Di Paolo D; Zancolli M; Pistoia V; Ponzoni M; Pastorino F
Cancer Lett; 2005 Oct; 228(1-2):181-6. PubMed ID: 15936140
[TBL] [Abstract][Full Text] [Related]
6. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.
Pagnan G; Stuart DD; Pastorino F; Raffaghello L; Montaldo PG; Allen TM; Calabretta B; Ponzoni M
J Natl Cancer Inst; 2000 Feb; 92(3):253-61. PubMed ID: 10655443
[TBL] [Abstract][Full Text] [Related]
7. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.
Brignole C; Pagnan G; Marimpietri D; Cosimo E; Allen TM; Ponzoni M; Pastorino F
Cancer Lett; 2003 Jul; 197(1-2):231-5. PubMed ID: 12880987
[TBL] [Abstract][Full Text] [Related]
9. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
[TBL] [Abstract][Full Text] [Related]
10. Anti-IL-10R antibody improves the therapeutic efficacy of targeted liposomal oligonucleotides.
Brignole C; Marimpietri D; Pastorino F; Di Paolo D; Pagnan G; Loi M; Piccardi F; Cilli M; Tradori-Cappai A; Arrigoni G; Pistoia V; Ponzoni M
J Control Release; 2009 Sep; 138(2):122-7. PubMed ID: 19427884
[TBL] [Abstract][Full Text] [Related]
11. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition.
Te Kronnie G; Timeus F; Rinaldi A; Crescenzio N; Spinelli M; Rosolen A; Ricotti E; Basso G
Int J Mol Med; 2004 Sep; 14(3):373-82. PubMed ID: 15289888
[TBL] [Abstract][Full Text] [Related]
12. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
[TBL] [Abstract][Full Text] [Related]
13. Enhancing radiosensitivity of Hela cells by combining transfection of bcl-2 c-myc ASODNs.
Li R; Cheng Y; Gao C
Bull Cancer; 2006 Nov; 93(11):E119-25. PubMed ID: 17145575
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
Loomis R; Carbone R; Reiss M; Lacy J
Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
Raschellà G; Negroni A; Skorski T; Pucci S; Nieborowska-Skorska M; Romeo A; Calabretta B
Cancer Res; 1992 Aug; 52(15):4221-6. PubMed ID: 1638535
[TBL] [Abstract][Full Text] [Related]
16. Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells.
Ebinuma H; Saito H; Kosuga M; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Okuyama T; Ishii H
J Cell Physiol; 2001 Jul; 188(1):56-66. PubMed ID: 11382922
[TBL] [Abstract][Full Text] [Related]
17. Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.
Loi M; Marchiò S; Becherini P; Di Paolo D; Soster M; Curnis F; Brignole C; Pagnan G; Perri P; Caffa I; Longhi R; Nico B; Bussolino F; Gambini C; Ribatti D; Cilli M; Arap W; Pasqualini R; Allen TM; Corti A; Ponzoni M; Pastorino F
J Control Release; 2010 Jul; 145(1):66-73. PubMed ID: 20346382
[TBL] [Abstract][Full Text] [Related]
18. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides.
Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y
J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.
Iversen PL; Arora V; Acker AJ; Mason DH; Devi GR
Clin Cancer Res; 2003 Jul; 9(7):2510-9. PubMed ID: 12855625
[TBL] [Abstract][Full Text] [Related]
20. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]